Hackett Patrick T. - 02 Jun 2025 Form 4 Insider Report for Outset Medical, Inc. (OM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Jun 2025, 16:26:53 UTC
Prior SEC filing
11 Mar 2025
Next SEC filing
05 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: John L Brottem For: Patrick T Hackett

Key filing fact

Hackett Patrick T. filed Form 4 for Outset Medical, Inc. (OM) on 04 Jun 2025.

Key facts

  • This page summarizes Hackett Patrick T.'s Form 4 filing for Outset Medical, Inc. (OM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Jun 2025, 16:26.

Change

  • Previous filing in this sequence was filed on 11 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001238606 Primary reporting owner

HACKETT PATRICK T

Relationship
Director
Address
3052 ORCHARD DRIVE, SAN JOSE
Signature
By: John L Brottem For: Patrick T Hackett
Signature date
04 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OM transaction

Common Stock

Award

Transaction value
$0
Shares
+8,983
Change %
+10%
Price
$0.000000
Shares after
95,172
Date
02 Jun 2025
Ownership
Direct
Footnotes
F1, F2
OM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
83,333
Date
02 Jun 2025
Ownership
GST Trust
OM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
41,666
Date
02 Jun 2025
Ownership
Hackett Family Fund
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Footnote F2

These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split").

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .